ATRA icon

Atara Biotherapeutics
ATRA

Upgrade to unlock
Buy
Hold
Sell

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
Avg. target
$6
34% upside
High target

1 analyst rating

positive
1  neutral
100%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Canaccord Genuity
Canaccord Genuity
John Newman
33% 1-yr ATRA win rate
13 Jan ‘26 yesterday